| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.17 | 0.4 |